Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletion

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Aliev, Gjumrakch ^a,b   Obrenovich, Mark E ^c   Tabrez, Shams ^d   Jabir, Nasimudeen R ^d   Reddy, V Prakash ^e   Li, Yi ^f   Burnstock, Geoffrey ^g,h   Cacabelos, Ramon ⁱ   Kamal, Mohammad Amjad ^d  

^a GALLY International Biomedical Research Consulting LLC   (United States)

^b University of Atlanta   (United States)

^c CLEVELAND STATE UNIVERSITY   (United States)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^e MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g ROYAL FREE HOSPITAL   (United Kingdom)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ CAMILO JOSÉ CELA UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ANTICANCER DRUG; BRAIN PATHOLOGIES; COLORECTAL CANCER; MITOCHONDRIAL DNA; PATHOGENIC FACTORS; PRIMARY BRAIN TUMORS; TRANSGENIC MICE;

CELL PROLIFERATION; NEURODEGENERATIVE DISEASES; NITRIC OXIDE; PATHOLOGY; TUMORS;

MITOCHONDRIA;

AMYLOID BETA PROTEIN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; HYPOXIA INDUCIBLE FACTOR 1; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOCHONDRIAL DNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ALZHEIMER DISEASE; CANCER GROWTH; CELL DIVISION; CELL MOTILITY; CELL PROLIFERATION; CELL VIABILITY; DNA DAMAGE; DNA SYNTHESIS; ELECTRON TRANSPORT; ENDOTHELIUM CELL; ETIOLOGY; GENE DELETION; HUMAN; IMMUNOREACTIVITY; LIVER CANCER; LIVER CELL; MACROPHAGE ACTIVATION; METASTATIC COLORECTAL CANCER; NEOPLASM; OXIDATIVE STRESS; PRIMARY TUMOR; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSGENIC MOUSE; ANIMAL; ENZYMOLOGY; METABOLISM; PATHOLOGY; ULTRASTRUCTURE;

ALZHEIMER DISEASE; ANIMALS; DNA, MITOCHONDRIAL; HUMANS; NEOPLASMS; NITRIC OXIDE; OXIDATIVE STRESS; SEQUENCE DELETION;

EID: 84877276332     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/962984     Document Type: Review

References (167)

1. Aliev G., Li Y., Palacios H. H., Obrenovich M. E., Oxidative stress induced mitochondrial DNA deletion as a hallmark for the drug development in the context of the cerebrovascular diseases. Recent Patents on Cardiovascular Drug Discovery 2011 6 3 222 241
2. Aliev G., Smith M. A., Seyidova D., Neal M. L., Shi J., Loizidou M., Turmaine M., Friedland R. P., Taylor I., Burnstock G., Perry G., Lamanna J. C., Increased expression of NOS and ET-1 immunoreactivity in human colorectal metastatic liver tumours is associated with selective depression of constitutive NOS immunoreactivity in vessel endothelium. Journal of Submicroscopic Cytology and Pathology 2002 34 1 37 50 2-s2.0-0036367123 (Pubitemid 40021935)
3. Aliev G., Palacios H. H., Lipsitt A. E., Fischbach K., Lamb B. T., Obrenovich M. E., Morales L., Gasimov E., Bragin V., Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease. Neurotoxicity Research 2009 16 3 293 305 2-s2.0-70349969737 10.1007/s12640-009- 9066-5
4. Clementi E., Brown G. C., Feelisch M., Moncada S., Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proceedings of the National Academy of Sciences of the United States of America 1998 95 13 7631 7636 2-s2.0-0032560572 10.1073/pnas.95.13.7631 (Pubitemid 28293304)
5. Beltrán B., Mathur A., Duchen M. R., Erusalimsky J. D., Moncada S., The effect of nitric oxide on cell respiration: a key to understanding its role in cell survival or death. Proceedings of the National Academy of Sciences of the United States of America 2000 97 26 14602 14607 2-s2.0-0034687662 10.1073/pnas.97.26.14602 (Pubitemid 32016622)
6. Moncada S., Erusalimsky J. D., Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nature Reviews Molecular Cell Biology 2002 3 3 214 220 2-s2.0-0036513249 10.1038/nrm762
7. Pacher P., Beckman J. S., Liaudet L., Nitric oxide and peroxynitrite in health and disease. Physiological Reviews 2007 87 1 315 424 2-s2.0-33846863589 10.1152/physrev.00029.2006 (Pubitemid 46217686)
8. Clementi E., Brown G. C., Foxwell N., Moncada S., On the mechanism by which vascular endothelial cells regulate their oxygen consumption. Proceedings of the National Academy of Sciences of the United States of America 1999 96 4 1559 1562 2-s2.0-0033573981 10.1073/pnas.96.4.1559 (Pubitemid 29098490)
9. de la Torre J. C., Aliev G., Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes. Journal of Cerebral Blood Flow and Metabolism 2005 25 6 663 672 2-s2.0-18944380149 10.1038/sj.jcbfm.9600057 (Pubitemid 40705602)
10. Greferath U., Bennie A., Kourakis A., Bartlett P. F., Murphy M., Barrett G. L., Enlarged cholinergic forebrain neurons and improved spatial learning in p75 knockout mice. European Journal of Neuroscience 2000 12 3 885 893 2-s2.0-0034124601 10.1046/j.1460-9568.2000.00976.x (Pubitemid 30168766)
11. Veng L. M., Granholm A. C., Rose G. M., Age-related sex differences in spatial learning and basal forebrain cholinergic neurons in F344 rats. Physiology and Behavior 2003 80 1 27 36 2-s2.0-0141887655 10.1016/S0031-9384(03) 00219-1 (Pubitemid 37249370)
12. Allard S., Leon W. C., Pakavathkumar P., Bruno M. A., Ribeiro-da-Silva A., Cuello A. C., Impact of the NGF maturation and degradation pathway on the cortical cholinergic system phenotype. The Journal of Neuroscience 2012 32 6 2002 2012 10.1523/JNEUROSCI.1144-11.2012
13. Hu J., Discher D. J., Bishopric N. H., Webster K. A., Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochemical and Biophysical Research Communications 1998 245 3 894 899 2-s2.0-0032576971 10.1006/bbrc.1998.8543 (Pubitemid 28414014)
14. Grimshaw M. J., Endothelins and hypoxia-inducible factor in cancer. Endocrine-Related Cancer 2007 14 2 233 244 2-s2.0-34547729187 10.1677/ERC-07-0057 (Pubitemid 47242625)
15. Giachini F. R. C., Zemse S. M., Carneiro F. S., Lima V. V., Carneiro Z. N., Callera G. E., Ergul A., Webb R. C., Tostes R. C., Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1/2-dependent pathway. The American Journal of Physiology 2009 296 2 H489 H496 2-s2.0-61949143689 10.1152/ajpheart.00251.2008
16. Xu J., Zhong N. S., The interaction of tumour necrosis factor alpha and endothelin-1 in pathogenetic models of asthma. Clinical and Experimental Allergy 1997 27 5 568 573 2-s2.0-0031005901 10.1111/j.1365-2222.1997.tb00746.x (Pubitemid 27241656)
17. Mullol J., Picado C., Endothelin in nasal mucosa: role in nasal function and inflammation. Clinical and Experimental Allergy 2000 30 2 172 177 2-s2.0-0033975632 10.1046/j.1365-2222.2000.00754.x (Pubitemid 30095660)
18. Kedzierski R. M., Yanagisawa M., Endothelin system: the double-edged sword in health and disease. Annual Review of Pharmacology and Toxicology 2001 41 851 876 2-s2.0-0035040924 10.1146/annurev.pharmtox.41.1.851 (Pubitemid 32385909)
19. Kohno M., Yokokawa K., Yasunari K., Kano H., Minami M., Yoshikawa J., Effect of the endothelin family of peptides on human coronary artery smooth-muscle cell migration. Journal of Cardiovascular Pharmacology 1998 31 supplement 1 S84 S89 2-s2.0-0031638089 (Pubitemid 128709877)
20. Khimji A. K., Rockey D. C., Endothelin-biology and disease. Cellular Signalling 2010 22 11 1615 1625 2-s2.0-77955659816 10.1016/j.cellsig.2010.05.002
21. Morris C. D., Rose A., Curwen J., Hughes A. M., Wilson D. J., Webb D. J., Specific inhibition of the endothelin A receptor with ZD4054: clinical and pre-clinical evidence. The British Journal of Cancer 2005 92 12 2148 2152 2-s2.0-22044435149 10.1038/sj.bjc.6602676 (Pubitemid 40966249)
22. Rosanò L., Spinella F., Di Castro V., Dedhar S., Nicotra M. R., Natali P. G., Bagnato A., Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma. Molecular Cancer Therapeutics 2006 5 4 833 842 2-s2.0-33646576837 10.1158/1535-7163.MCT-05-0523 (Pubitemid 43724582)
23. Rosanò L., Spinella F., Di Castro V., Nicotra M. R., Dedhar S., de Herreros A. G., Natali P. G., Bagnato A., Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells. Cancer Research 2005 65 24 11649 11657 2-s2.0-29144495415 10.1158/0008-5472.CAN-05-2123 (Pubitemid 41821725)
24. Shichiri M., Sedivy J. M., Marumo F., Hirata Y., Endothelin-1 is a potent survival factor for c-Myc-dependent apoptosis. Molecular Endocrinology 1998 12 2 172 180 2-s2.0-0032230175 (Pubitemid 30658235)
25. Wiesmann F., Veeck J., Galm O., Hartmann A., Esteller M., Knüchel R., Dahl E., Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer. Breast Cancer Research 2009 11 3, article R34 10.1186/bcr2319
26. Rosenblatt R., Valdman A., Cheng L., Lopez-Beltran A., Montironi R., Ekman P., Egevad L., Endothelin-1 expression in prostate cancer and high grade prostatic intraepithelial neoplasia. Analytical and Quantitative Cytology and Histology 2009 31 3 137 142 2-s2.0-67849124048
27. Grimshaw M. J., Naylor S., Balkwill F. R., Endothelin-2 is a hypoxia-induced autocrine survival factor for breast tumor cells. Molecular Cancer Therapeutics 2002 1 14 1273 1281 2-s2.0-0038380366
28. 2+ Life Sciences 2008 82 13-14 764 771 2-s2.0-40649127132 10.1016/j.lfs.2008.01.008
29. Borzacchiello G., Mogavero S., Tortorella G., Catone G., Russo M., Expression of endothelin-1 and endothelin receptor A in canine ovarian tumours. Reproduction in Domestic Animals 2010 45 6 e465 e468 2-s2.0-78649579099 10.1111/j.1439-0531.2010.01580.x
30. Evans N. J., Walker J. W., Endothelin receptor dimers evaluated by FRET, ligand binding, and calcium mobilization. Biophysical Journal 2008 95 1 483 492 2-s2.0-46749087878 10.1529/biophysj.107.119206
31. Grant K., Knowles J., Dawas K., Burnstock G., Taylor I., Loizidou M., Mechanisms of endothelin 1-stimulated proliferation in colorectal cancer cell lines. The British Journal of Surgery 2007 94 1 106 112 2-s2.0-33846450992 10.1002/bjs.5536 (Pubitemid 46142740)
32. Aliyev A., Seyidova D., Rzayev N., Obrenovich M. E., Lamb B. T., Chen S. G., Smith M. A., Perry G., de la Torre J. C., Aliev G., Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease? Neurological Research 2004 26 5 547 553 2-s2.0-3042806294 10.1179/01610425017613 (Pubitemid 38879237)
33. Aliyev A., Chen S. G., Seyidova D., Smith M. A., Perry G., de la Torre J., Aliev G., Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. Journal of the Neurological Sciences 2005 229-230 285 292 2-s2.0-14844311901 10.1016/j.jns.2004.11.040 (Pubitemid 40341595)
34. Liu S., Premont R. T., Kontos C. D., Zhu S., Rockey D. C., A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. Nature Medicine 2005 11 9 952 958 2-s2.0-24744444714 10.1038/nm1289 (Pubitemid 41294440)
35. Morris G. E., Nelson C. P., Standen N. B., Challiss R. A. J., Willets J. M., Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2. Cardiovascular Research 2010 85 3 424 433 2-s2.0-74249083425 10.1093/cvr/cvp310
36. Obrenovich M. E., Morales L. A., Cobb C. J., Shenk J. C., Méndez G. M., Fischbach K., Smith M. A., Qasimov E. K., Perry G., Aliev G., Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation. Journal of Cellular and Molecular Medicine 2009 13 5 853 865 2-s2.0-67249105741 10.1111/j.1582-4934.2008.00512.x
37. Obrenovich M. E., Palacios H. H., Gasimov E., Leszek J., Aliev G., The GRK2 overexpression is a primary hallmark of mitochondrial lesions during early alzheimer disease. Cardiovascular Psychiatry and Neurology 2009 2009 14 327360 10.1155/2009/327360
38. Obrenovich M. E., Smith M. A., Siedlak S. L., Chen S. G., de la Torre J. C., Perry G., Aliev G., Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions. Neurotoxicity Research 2006 10 1 43 56 2-s2.0-33750617659 10.1007/BF03033333
39. Vroon A., Heijnen C. J., Kavelaars A., GRKs and arrestins: regulators of migration and inflammation. Journal of Leukocyte Biology 2006 80 6 1214 1221 2-s2.0-33845412884 10.1189/jlb.0606373 (Pubitemid 44904958)
40. Penela P., Murga C., Ribas C., Lafarga V., Mayor F., The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets. The British Journal of Pharmacology 2010 160 4 821 832 2-s2.0-77952840083 10.1111/j.1476-5381.2010.00727.x
41. Guo J., Chen H., Ho J., Mancini J., Sontag T., Laporte S. A., Richard D. E., Lebrun J. J., TGF β -induced GRK2 expression attenuates AngII-regulated vascular smooth muscle cell proliferation and migration. Cellular Signalling 2009 21 6 899 905 2-s2.0-62749127825 10.1016/j.cellsig.2009.01.037
42. Dao H. H., Bouvet C., Moreau S., Beaucage P., Larivière R., Servant M. J., de Champlain J., Moreau P., Endothelin is a dose-dependent trophic factor and a mitogen in small arteries in vivo. Cardiovascular Research 2006 71 1 61 68 2-s2.0-33744916079 10.1016/j.cardiores.2006.02.029 (Pubitemid 44218975)
43. Peppel K., Jacobson A., Huang X., Murray J. P., Oppermann M., Freedman N. J., Overexpression of G protein-coupled receptor kinase-2 in smooth muscle cells attenuates mitogenic signaling via G protein-coupled and platelet-derived growth factor receptors. Circulation 2000 102 7 793 799 2-s2.0-0033869812 (Pubitemid 30643287)
44. Meloni A. R., Fralish G. B., Kelly P., Salahpour A., Chen J. K., Wechsler-Reya R. J., Lefkowitz R. J., Caron M. G., Smoothened signal transduction is promoted by G protein-coupled receptor kinase 2. Molecular and Cellular Biology 2006 26 20 7550 7560 2-s2.0-33749590571 10.1128/MCB.00546-06 (Pubitemid 44547705)
45. Jiang X., Yang P., Ma L., Kinase activity-independent regulation of cyclin pathway by GRK2 is essential for zebrafish early development. Proceedings of the National Academy of Sciences of the United States of America 2009 106 25 10183 10188 2-s2.0-67649836304 10.1073/pnas.0812105106
46. Ho J., Cocolakis E., Dumas V. M., Posner B. I., Laporte S. A., Lebrun J. J., The G protein-coupled receptor kinase-2 is a TGF β -inducible antagonist of TGF β signal transduction. The EMBO Journal 2005 24 18 3247 3258 2-s2.0-25144432973 10.1038/sj.emboj.7600794 (Pubitemid 41348699)
47. Salcedo A., Mayor F. Jr., Penela P., Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2. The EMBO Journal 2006 25 20 4752 4762 2-s2.0-33750208522 10.1038/sj.emboj.7601351 (Pubitemid 44607021)
48. Jiménez-Sainz M. C., Murga C., Kavelaars A., Jurado-Pueyo M., Krakstad B. F., Heijnen C. J., Mayor F. Jr., Aragay A. M., G protein-coupled receptor kinase 2 negatively regulates chemokine signaling at a level downstream from G protein subunits. Molecular Biology of the Cell 2006 17 1 25 31 2-s2.0-30044434455 10.1091/mbc.E05-05-0399 (Pubitemid 43049458)
49. Métayé T., Levillain P., Kraimps J. L., Perdrisot R., Immunohistochemical detection, regulation and antiproliferative function of G-protein-coupled receptor kinase 2 in thyroid carcinomas. Journal of Endocrinology 2008 198 1 101 110 2-s2.0-47849125977 10.1677/JOE-07-0562 (Pubitemid 352038189)
50. Métayé T., Menet E., Guilhot J., Kraimps J. L., Expression and activity of G protein-coupled receptor kinases in differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 2002 87 7 3279 3286 2-s2.0-0036324072 10.1210/jc.87.7.3279 (Pubitemid 34816377)
51. Prowatke I., Devens F., Benner A., Gröne E. F., Mertens D., Gröne H. J., Lichter P., Joos S., Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays. The British Journal of Cancer 2007 96 1 82 88 2-s2.0-33846230600 10.1038/sj.bjc.6603490 (Pubitemid 46094643)
52. Wan K. F., Sambi B. S., Tate R., Waters C., Pyne N. J., The inhibitory γ subunit of the type 6 retinal cGMP phosphodiesterase functions to link c-Src and G-protein-coupled receptor kinase 2 in a signaling unit that regulates p42/p44 mitogen-activated protein kinase by epidermal growth factor. The Journal of Biological Chemistry 2003 278 20 18658 18663 2-s2.0-0038381488 10.1074/jbc.M212103200 (Pubitemid 36799493)
53. Bliziotes M., Gunness M., Zhang X. W., Nissenson R., Wiren K., Reduced G-protein-coupled-receptor kinase 2 activity results in impairment of osteoblast function. Bone 2000 27 3 367 373 2-s2.0-0033838695 10.1016/S8756-3282(00)00338- 0 (Pubitemid 30658119)
54. Shankar A., Loizidou M., Aliev G., Fredericks S., Holt D., Boulos P. B., Burnstock G., Taylor I., Raised endothelin 1 levels in patients with colorectal liver metastases. The British Journal of Surgery 1998 85 4 502 506 2-s2.0-0031925028 10.1046/j.1365-2168.1998.00660.x (Pubitemid 28175443)
55. Aliev G., Smith M. A., Obrenovich M. E., de la Torre J. C., Perry G., Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Alzheimer disease. Neurotoxicity Research 2003 5 7 491 504 2-s2.0-1342285214 10.1007/BF03033159
56. Aliev G., Smith M. A., Seyidova D., Neal M. L., Lamb B. T., Nunomura A., Gasimov E. K., Vinters H. V., Perry G., Lamanna J. C., Friedland R. P., The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathology 2002 12 1 21 35 2-s2.0-0036133115 (Pubitemid 33131359)
57. Aliev G., Gasimov E., Obrenovich M. E., Fischbach K., Shenk J. C., Smith M. A., Perry G., Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: Implication in the pathogenesis of Alzheimer's disease. Vascular Health and Risk Management 2008 4 3 721 730 2-s2.0-47849127831 (Pubitemid 352037931)
58. Aliev G., Smith M. A., de la Torre J. C., Perry G., Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion 2004 4 5-6 649 663 2-s2.0-10644276189 10.1016/j.mito.2004.07.018 (Pubitemid 39650918)
59. Nelson J. B., Udan M. S., Guruli G., Pflug B. R., Endothelin-1 inhibits apoptosis in prostate cancer. Neoplasia 2005 7 7 631 637 2-s2.0-23244454378 10.1593/neo.04787 (Pubitemid 41099416)
60. Buga G. M., Ignarro L. J., Nitric oxide and cancer. Nitric Oxide 2000 895 920
61. Fukuda K., Yanagida T., Okuda S., Tamaki K., Ando T., Fujishima M., Role of endothelin as a mitogen in experimental glomerulonephritis in rats. Kidney International 1996 49 5 1320 1329 2-s2.0-0029991748 (Pubitemid 26166406)
62. Bagnato A., Tecce R., Di Castro V., Catt K. J., Activation of mitogenic signaling by endothelin 1 in ovarian carcinoma cells. Cancer Research 1997 57 7 1306 1311 2-s2.0-0030903110 (Pubitemid 27152556)
63. Kozawa O., Kawamura H., Hatakeyama D., Matsuno H., Uematsu T., Endothelin-1 induces vascular endothelial growth factor synthesis in osteoblasts: involvement of p38 mitogen-activated protein kinase. Cellular Signalling 2000 12 6 375 380 2-s2.0-0034095640 10.1016/S0898-6568(00)00061-9 (Pubitemid 30417600)
64. Grant K., Loizidou M., Taylor I., Endothelin-I: a multifunctional molecule in cancer. The British Journal of Cancer 2003 88 2 163 166 2-s2.0-0037467569 10.1038/sj.bjc.6700750 (Pubitemid 36255831)
65. Özdogan O., Gören M. Z., Ratip S., Giral A., Moini H., Enç F., Birsel S., Berkman K., Tözün N., Role of endothelin-1 in a cirrhotic rat model with endotoxin induced acute renal failure. Hepatology Research 2002 24 2 114 124 2-s2.0-0036788931 10.1016/S1386-6346(02)00082-7
66. Anggrahini D. W., Emoto N., Nakayama K., Widyantoro B., Adiarto S., Iwasa N., Nonaka H., Rikitake Y., Kisanuki Y. Y., Yanagisawa M., Hirata K. I., Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation. Cardiovascular Research 2009 82 1 143 151 2-s2.0-62349111262 10.1093/cvr/cvp026
67. Niedbala W., Wei X. Q., Campbell C., Thomson D., Komai-Koma M., Liew F. Y., Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor β 2 expression via cGMP. Proceedings of the National Academy of Sciences of the United States of America 2002 99 25 16186 16191 2-s2.0-0037058984 10.1073/pnas.252464599 (Pubitemid 35462770)
68. Yagihashi N., Kasajima H., Sugai S., Matsumoto K., Ebina Y., Morita T., Murakami T., Yagihashi S., Increased in situ expression of nitric oxide synthase in human colorectal cancer. Virchows Archiv 2000 436 2 109 114 2-s2.0-0034052126 (Pubitemid 30128756)
69. Fang F. C., Vazquez-Torres A., Nitric oxide production by human macrophages: there's NO doubt about it. The American Journal of Physiology 2002 282 5 L941 L943 2-s2.0-0036081210 (Pubitemid 34654609)
70. Kashfi K., Ryann Y., Qiao L. L., Williams J. L., Chen J., Del Soldato P., Traganos F., Rigas B., Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect. Journal of Pharmacology and Experimental Therapeutics 2002 303 3 1273 1282 2-s2.0-0036894884 10.1124/jpet.102.042754 (Pubitemid 35424414)
71. Galea E., Feinstein D. L., Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB Journal 1999 13 15 2125 2137 2-s2.0-0032779378
72. Webber K. M., Casadesus G., Zhu X., Obrenovich M. E., Atwood C. S., Perry G., Bowen R. L., Smith M. A., The cell cycle and hormonal fluxes in Alzheimer disease: a novel therapeutic target. Current Pharmaceutical Design 2006 12 6 691 697 2-s2.0-33645288896 10.2174/138161206775474305
73. Nagy Z., Cell cycle regulatory failure in neurones: causes and consequences. Neurobiology of Aging 2000 21 6 761 769 2-s2.0-0033634990 10.1016/S0197-4580(00)00223-2
74. Cash A. D., Aliev G., Siedlak S. L., Nunomura A., Fujioka H., Zhu X., Raina A. K., Vinters H. V., Tabaton M., Johnson A. B., Paula-Barbosa M., Avíla J., Jones P. K., Castellani R. J., Smith M. A., Perry G., Microtubule reduction in Alzheimer's disease and aging is independent of τ filament formation. The American Journal of Pathology 2003 162 5 1623 1627 2-s2.0-0242600546 (Pubitemid 36512845)
75. Masliah E., Terry R., The role of synaptic proteins in the pathogenesis of disorders of the central nervous system. Brain Pathology 1993 3 1 77 85 2-s2.0-0027511905 (Pubitemid 23046378)
76. Janicki S. M., Stabler S. M., Monteiro M. J., Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest. Neurobiology of Aging 2000 21 6 829 836 2-s2.0-0033637232 10.1016/S0197-4580(00)00222-0
77. Janicki S. M., Monteiro M. J., Presenilin overexpression arrests cells in the G1 phase of the cell cycle: arrest potentiated by the Alzheimer's disease PS2(N141I) mutant. The American Journal of Pathology 1999 155 1 135 144 2-s2.0-0032984214 (Pubitemid 29318712)
78. Soriano S., Kang D. E., Fu M., Pestell R., Chevallier N., Zheng H., Koo E. H., Presenilin 1 negatively regulates β -catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of β -amyloid precursor protein and notch processing. Journal of Cell Biology 2001 152 4 785 794 2-s2.0-0035911156 10.1083/jcb.152.4.785 (Pubitemid 34280163)
79. Piazza A., Lynch M. A., Neuroinflammatory changes increase the impact of stressors on neuronal function. Biochemical Society Transactions 2009 37 1 303 307 2-s2.0-59749106625 10.1042/BST0370303
80. Ong W. Y., Farooqui A. A., Iron, neuroinflammation, and Alzheimer's disease. Journal of Alzheimer's Disease 2005 8 2 183 200 2-s2.0-32444439095 (Pubitemid 43227164)
81. Park D. S., Obeidat A., Giovanni A., Greene L. A., Cell cycle regulators in neuronal death evoked by excitotoxic stress: implications for neurodegeneration and its treatment. Neurobiology of Aging 2000 21 6 771 781 2-s2.0-0033636761 10.1016/S0197-4580(00)00220-7
82. Yang Y., Geldmacher D. S., Herrup K., DNA replication precedes neuronal cell death in Alzheimer's disease. The Journal of Neuroscience 2001 21 8 2661 2668 2-s2.0-0035871660 (Pubitemid 32298208)
83. Mosch B., Morawski M., Mittag A., Lenz D., Tarnok A., Arendt T., Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease. The Journal of Neuroscience 2007 27 26 6859 6867 2-s2.0-34347351340 10.1523/JNEUROSCI.0379-07.2007 (Pubitemid 47015903)
84. Cramer P. E., Cirrito J. R., Wesson D. W., Lee C. Y. D., Karlo J. C., Zinn A. E., Casali B. T., Restivo J. L., Goebel W. D., James M. J., Brunden K. R., Wilson D. A., Landreth G. E., ApoE-directed therapeutics rapidly clear β -amyloid and reverse deficits in AD mouse models. Science 2012 335 6075 1503 1506 10.1126/science.1217697
85. Schubert D., Cole G., Saitoh T., Oltersdorf T., Amyloid beta protein precursor in a mitogen. Biochemical and Biophysical Research Communications 1989 162 1 83 88 2-s2.0-0024318406 (Pubitemid 19185830)
86. Milward E. A., Papadopoulos R., Fuller S. J., Moir R. D., Small D., Beyreuther K., Masters C. L., The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 1992 9 1 129 137 2-s2.0-0026663993 10.1016/0896-6273(92)90228- 6
87. Varvel N. H., Bhaskar K., Patil A. R., Pimplikar S. W., Herrup K., Lamb B. T., A β oligomers induce neuronal cell cycle events in Alzheimer's disease. The Journal of Neuroscience 2008 28 43 10786 10793 2-s2.0-58149151433 10.1523/JNEUROSCI.2441-08.2008
88. Neve R. L., McPhie D. L., Dysfunction of amyloid precursor protein signaling in neurons leads to DNA synthesis and apoptosis. Biochimica et Biophysica Acta 2007 1772 4 430 437 2-s2.0-33947170664 10.1016/j.bbadis.2006.10. 008 (Pubitemid 46400381)
89. Sherr C. J., G1 phase progression: cycling on cue. Cell 1994 79 4 551 555 2-s2.0-0028171292 10.1016/0092-8674(94)90540-1 (Pubitemid 24363798)
90. Meikrantz W., Schlegel R., Apoptosis and the cell cycle. Journal of Cellular Biochemistry 1995 58 2 160 174 2-s2.0-0029048745 10.1002/jcb.240580205
91. Pasquier E., Carré M., Pourroy B., Camoin L., Rebaï O., Briand C., Braguer D., Antiangiogenic activity of paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway. Molecular Cancer Therapeutics 2004 3 10 1301 1310 2-s2.0-7444269580 (Pubitemid 39440174)
92. Sieradzki A., Yendluri B. B., Palacios H. H., Parvathaneni K., Reddy V. P., Obrenovich M. E., Gasiorowski K., Leszek J., Aliev G., Implication of oncogenic signaling pathways as a treatment strategy for neurodegenerative disorders-contemporary approaches. CNS & Neurological Disorders-Drug Targets 2011 10 2 175 183 2-s2.0-79961001802
93. Lipinski B., Hydroxyl radical and its scavengers in health and disease. Oxidative Medicine and Cellular Longevity 2011 2011 9 809696 10.1155/2011/809696
94. Obrenovich M. E., Li Y., Parvathaneni K., Yendluri B. B., Palacios H. H., Leszek J., Aliev G., Antioxidants in health, disease and aging. CNS and Neurological Disorders-Drug Targets 2011 10 2 192 207 2-s2.0-79551662910
95. Drewes G., Lichtenberg-Kraag B., Döring F., Mandelkow E. M., Biernat J., Goris J., Dorée M., Mandelkow E., Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. The EMBO Journal 1992 11 6 2131 2138
96. Suzuki T., Oishi M., Marshak D. R., Czernik A. J., Nairn A. C., Greengard P., Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. The EMBO Journal 1994 13 5 1114 1122 2-s2.0-0028295848 (Pubitemid 24074718)
97. Nagy Z., Esiri M. M., Smith A. D., Expression of cell division markers in the hippocampus in Alzheimer's disease and other nenrodegenerative conditions. Acta Neuropathologica 1997 93 3 294 300 2-s2.0-0031043049 10.1007/s004010050617 (Pubitemid 27104426)
98. Vincent I., Jicha G., Rosado M., Dickson D. W., Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. The Journal of Neuroscience 1997 17 10 3588 3598 2-s2.0-0031006939 (Pubitemid 27200586)
99. Busser J., Geldmacher D. S., Herrup K., Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. The Journal of Neuroscience 1998 18 8 2801 2807 2-s2.0-0032522911 (Pubitemid 28163210)
100. Kranenburg O., van der Eb A. J., Zantema A., Cyclin D1 is an essential mediator of apoptotic neuronal cell death. The EMBO Journal 1996 15 1 46 54 2-s2.0-0030031514 (Pubitemid 26020387)
101. Arendt T., Holzer M., Gärtner U., Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease. Journal of Neural Transmission 1998 105 8-9 949 960 2-s2.0-0031737550 10.1007/s007020050104 (Pubitemid 28539839)
102. Smith M. Z., Nagy Z., Esiri M. M., Cell cycle-related protein expression in vascular dementia and Alzheimer's disease. Neuroscience Letters 1999 271 1 45 48 2-s2.0-0033551712 10.1016/S0304-3940(99)00509-1 (Pubitemid 29369191)
103. Ledesma M. D., Correas I., Avila J., Diaz-Nido J., Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease. FEBS Letters 1992 308 2 218 224 2-s2.0-0026694067 10.1016/0014-5793(92) 81278-T
104. Tsujioka Y., Takahashi M., Tsuboi Y., Yamamoto T., Yamada T., Localization and expression of cdc2 and cdk4 in Alzheimer brain tissue. Dementia and Geriatric Cognitive Disorders 1999 10 3 192 198 2-s2.0-0032907063 10.1159/000017119 (Pubitemid 29224495)
105. Giovanni A., Wirtz-Brugger F., Keramaris E., Slack R., Park D. S., Involvement of cell cycle elements, cyclin-dependent kinases, pRB, and E2F · DP, in B-amyloid-induced neuronal death. The Journal of Biological Chemistry 1999 274 27 19011 19016 2-s2.0-0033516567 10.1074/jbc.274.27.19011 (Pubitemid 29314095)
106. McShea A., Harris P. L. R., Webster K. R., Wahl A. F., Smith M. A., Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. The American Journal of Pathology 1997 150 6 1933 1939 2-s2.0-0030921323 (Pubitemid 27233067)
107. Park D. S., Levine B., Ferrari G., Greene L. A., Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons. The Journal of Neuroscience 1997 17 23 8975 8983 2-s2.0-0030694346 (Pubitemid 27498426)
108. Tanaka T., Zhong J., Iqbal K., Trenkner E., Grundke-Iqbal I., The regulation of phosphorylation of τ in SY5Y neuroblastoma cells: the role of protein phosphatases. FEBS Letters 1998 426 2 248 254 2-s2.0-0032540459 10.1016/S0014-5793(98)00346-9 (Pubitemid 28198136)
109. Baumann K., Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Letters 1993 336 3 417 424 2-s2.0-0027757042 10.1016/0014-5793(93)80849-P (Pubitemid 24036992)
110. Pei J. J., Grundke-Iqbal I., Iqbal K., Bogdanovic N., Winblad B., Cowburn R. F., Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Research 1998 797 2 267 277 2-s2.0-0032578024 10.1016/S0006-8993(98)00296-0 (Pubitemid 28332739)
111. Flaherty D. B., Soria J. P., Tomasiewicz H. G., Wood J. G., Phosphorylation of human tau protein by microtubule-associated kinases: GSK3 β and cdk5 are key participants. Journal of Neuroscience Research 2000 62 3 463 472 10.1002/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO;2-7
112. Bennecib M., Gong C. X., Grundke-Iqbal I., Iqbal K., Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS Letters 2000 485 1 87 93 2-s2.0-0034680902 10.1016/S0014-5793(00)02203-1
113. Takahashi M., Iseki E., Kosaka K., Cdk5 and munc-18/p67 co-localization in early stage neurofibrillary tangles-bearing neurons in Alzheimer type dementia brains. Journal of the Neurological Sciences 2000 172 1 63 69 2-s2.0-0033987059 10.1016/S0022-510X(99)00291-9 (Pubitemid 30006983)
114. Ahlijanian M. K., Barrezueta N. X., Williams R. D., Jakowski A., Kowsz K. P., McCarthy S., Coskran T., Carlo A., Seymour P. A., Burkhardt J. E., Nelson R. B., McNeish J. D., Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proceedings of the National Academy of Sciences of the United States of America 2000 97 6 2910 2915 2-s2.0-12944268979 10.1073/pnas.040577797 (Pubitemid 30159271)
115. Vincent I., Rosado M., Davies P., Mitotic mechanisms in Alzheimer's disease? Journal of Cell Biology 1996 132 3 413 425 2-s2.0-0030062245 10.1083/jcb.132.3.413 (Pubitemid 26053445)
116. Lee K. Y., Clark A. W., Rosales J. L., Chapman K., Fung T., Johnston R. N., Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. Neuroscience Research 1999 34 1 21 29 2-s2.0-0032988741 10.1016/S0168-0102(99) 00026-7 (Pubitemid 29245996)
117. Shimohama S., Kamiya S., Niguchi T., Sumida Y., Fujimoto S., Differential involvement of small G proteins in Alzheimer's disease. International Journal of Molecular Medicine 1999 3 6 597 600 2-s2.0-0033145902
118. North S., El-Ghissassi F., Pluquet O., Verhaegh G., Hainaut P., The cytoprotective aminothiol WR1065 activates p21(waf-1) and down regulates cell cycle progression through a p53-dependent pathway. Oncogene 2000 19 9 1206 1214 2-s2.0-0034708220 (Pubitemid 30157551)
119. Gärtner U., Holzer M., Heumann R., Arendt T., Induction of p21(ras) in Alzheimer pathology. NeuroReport 1995 6 10 1441 1444 2-s2.0-0028981791
120. Masliah E., Mallory M., Alford M., Hansen L. A., Saitoh T., Immunoreactivity of the nuclear antigen p105 is associated with plaques and tangles in Alzheimer's disease. Laboratory Investigation 1993 69 5 562 569 2-s2.0-0027131813 (Pubitemid 24004492)
121. de la Monte S. M., Sohn Y. K., Wands J. R., Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. Journal of the Neurological Sciences 1997 152 1 73 83 2-s2.0-0030831489 10.1016/S0022-510X(97)00131-7 (Pubitemid 27469712)
122. Lüth H. J., Holzer M., Gertz H. J., Arendt T., Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21(ras) and p16(INK4a). Brain Research 2000 852 1 45 55 2-s2.0-0343340057 10.1016/S0006-8993(99)02178-2 (Pubitemid 30017732)
123. Smits V. A. J., Klompmaker R., Arnaud L., Rijksen G., Nigg E. A., Medema R. H., Polo-like kinase-1 is a target of the DNA damage checkpoint. Nature Cell Biology 2000 2 9 672 676 2-s2.0-0034282252 10.1038/35023629
124. Drewes G., Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcineurin and phosphatase-2A. FEBS Letters 1993 336 3 425 432 2-s2.0-0027753055 10.1016/0014-5793(93)80850-T (Pubitemid 24036993)
125. Garver T. D., Lehman R. A. W., Billingsley M. L., Microtubule assembly competence analysis of freshly-biopsied human tau, dephosphorylated tau, and Alzheimer tau. Journal of Neuroscience Research 1996 44 1 12 20 10.1002/(SICI)1097-4547(19960401)44:1<12::AID-JNR2>3.0.CO;2-L (Pubitemid 26108846)
126. Sontag E., Nunbhakdi-Craig V., Lee G., Brandt R., Kamibayashi C., Kuret J., White C. L., Mumby M. C., Bloom G. S., Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies. The Journal of Biological Chemistry 1999 274 36 25490 25498 2-s2.0-0033520355 10.1074/jbc.274.36.25490 (Pubitemid 29418573)
127. Husseman J. W., Nochlin D., Vincent I., Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases. Neurobiology of Aging 2000 21 6 815 828 2-s2.0-0033635551 10.1016/S0197-4580(00)00221-9
128. Ding X. L., Husseman J., Tomashevski A., Nochlin D., Jin L. W., Vincent I., The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease. The American Journal of Pathology 2000 157 6 1983 1990 2-s2.0-0033635191
129. Trejo J., Massamiri T., Deng T., Dewji N. N., Bayney R. M., Brown J. H., A direct role for protein kinase C and the transcription factor jun/AP-1 in the regulation of the Alzheimer's β -amyloid precursor protein gene. The Journal of Biological Chemistry 1994 269 34 21682 21690 2-s2.0-0028106342 (Pubitemid 24274808)
130. Lanius R. A., Wagey R., Sahl B., Beattie B. L., Feldman H., Pelech S. L., Krieger C., Protein kinase C activity and protein levels in Alzheimer's disease. Brain Research 1997 764 1-2 75 80 2-s2.0-0030768286 10.1016/S0006-8993(97)00422-8 (Pubitemid 27380641)
131. Tsujio I., Tanaka T., Kudo T., Nishikawa T., Shinozaki K., Grundke-Iqbal I., Iqbal K., Takeda M., Inactivation of glycogen synthase kinase-3 by protein kinase C δ: implications for regulation of τ phosphorylation. FEBS Letters 2000 469 1 111 117 2-s2.0-0034598963 10.1016/S0014-5793(00)01234-5 (Pubitemid 30119880)
132. Nakai M., Hojo K., Taniguchi T., Terashima A., Kawamata T., Hashimoto T., Maeda K., Tanaka C., PKC and tyrosine kinase involvement in amyloid β (25-35)-induced chemotaxis of microglia. NeuroReport 1998 9 15 3467 3470 2-s2.0-0032569636 (Pubitemid 28566131)
133. Singh T. J., Zaidi T., Grundke-Iqbal I., Iqbal K., Non-proline-dependent protein kinases phosphorylate several sites found in tau from Alzheimer disease brain. Molecular and Cellular Biochemistry 1996 154 2 143 151 2-s2.0-0030067749 10.1007/BF00226782 (Pubitemid 26038057)
134. Marambaud P., Ancolio K., da Costa C. A., Checler F., Effect of protein kinase A inhibitors on the production of A β 40 and A β 42 by human cells expressing normal and Alzheimer's disease-linked mutated β APP and presenilin 1. The British Journal of Pharmacology 1999 126 5 1186 1190 2-s2.0-0033014431 (Pubitemid 29123754)
135. Kawamata T., Taniguchi T., Mukai H., Kitagawa M., Hashimoto T., Maeda K., Ono Y., Tanaka C., A protein kinase, PKN, accumulates in Alzheimer neurofibrillary tangles and associated endoplasmic reticulum-derived vesicles and phosphorylates tau protein. The Journal of Neuroscience 1998 18 18 7402 7410 2-s2.0-0032530750 (Pubitemid 28425824)
136. Tanaka T., Tsujio I., Nishikawa T., Shinosaki K., Kudo T., Takeda M., Significance of tau phosphorylation and protein kinase regulation in the pathogenesis of Alzheimer disease. Alzheimer Disease and Associated Disorders 2000 14 supplement 1 S18 S24 2-s2.0-0034086160 10.1097/00002093-200000001-00004 (Pubitemid 30406768)
137. Zubenko G. S., Stiffler J. S., Hughes H. B., Martinez A. J., Reductions in brain phosphatidylinositol kinase activities in Alzheimer's disease. Biological Psychiatry 1999 45 6 731 736 2-s2.0-0033558966 10.1016/S0006-3223(98) 00073-0 (Pubitemid 29159049)
138. Anderton B. H., Dayanandan R., Killick R., Lovestone S., Does dysregulation of the Notch and wingless/Wnt pathways underlie the pathogenesis of Alzheimer's disease? Molecular Medicine 2000 6 2 54 59 2-s2.0-0033959997 (Pubitemid 30070666)
139. Yuan J., Yankner B. A., Apoptosis in the nervous system. Nature 2000 407 6805 802 809 2-s2.0-0034641936 10.1038/35037739
140. Luedecking E. K., DeKosky S. T., Mehdi H., Ganguli M., Kamboh M. I., Analysis of genetic polymorphisms in the transforming growth factor- β 1 gene and the risk of Alzheimer's disease. Human Genetics 2000 106 5 565 569 2-s2.0-0034045634 10.1007/s004390050026 (Pubitemid 30406684)
141. Luterman J. D., Haroutunian V., Yemul S., Ho L., Purohit D., Aisen P. S., Mohs R., Pasinetti G. M., Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Archives of Neurology 2000 57 8 1153 1160 2-s2.0-0033876817 (Pubitemid 30644662)
142. Arendt T., Holzer M., Großmann A., Zedlick D., Brückner M. K., Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease. Neuroscience 1995 68 1 5 18 2-s2.0-0029066704 10.1016/0306-4522(95) 00146-A
143. Zhu X., Castellani R. J., Takeda A., Nunomura A., Atwood C. S., Perry G., Smith M. A., Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the "two hit" hypothesis. Mechanisms of Ageing and Development 2001 123 1 39 46 2-s2.0-0034797352 10.1016/S0047-6374(01)00342-6 (Pubitemid 32972257)
144. Lu Q., Soria J. P., Wood J. G., p44(mpk) MAP kinase induces Alzheimer type alterations in tau function and in primary hippocampal neurons. The Journal of Neuroscience Research 1993 35 4 439 444 2-s2.0-0027335781 (Pubitemid 23195648)
145. Perry G., Roder H., Nunomura A., Takeda A., Friedlich A. L., Zhu X., Raina A. K., Holbrook N., Siedlak S. L., Harris P. L. R., Smith M. A., Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. NeuroReport 1999 10 11 2411 2415 2-s2.0-0033516947 (Pubitemid 29367948)
146. Reynolds C. H., Betts J. C., Blackstock W. P., Nebreda A. R., Anderton B. H., Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3 β Journal of Neurochemistry 2000 74 4 1587 1595 2-s2.0-0034067992 10.1046/j.1471-4159.2000.0741587.x (Pubitemid 30163980)
147. 2+-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles. The EMBO Journal 1990 9 11 3539 3544 2-s2.0-0025013270
148. Hensley K., Floyd R. A., Zheng N. Y., Nael R., Robinson K. A., Nguyen X., Pye Q. N., Stewart C. A., Geddes J., Markesbery W. R., Patel E., Johnson G. V. W., Bing G., p38 Kinase is activated in the Alzheimer's disease brain. Journal of Neurochemistry 1999 72 5 2053 2058 2-s2.0-0033043939 10.1046/j.1471-4159. 1999.0722053.x (Pubitemid 29186010)
149. Zhu X., Rottkamp C. A., Boux H., Takeda A., Perry G., Smith M. A., Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 2000 59 10 880 888 2-s2.0-0033782845
150. Zhu X., Raina A. K., Rottkamp C. A., Aliev G., Perry G., Boux H., Smith M. A., Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. Journal of Neurochemistry 2001 76 2 435 441 2-s2.0-0035142804 10.1046/j.1471-4159.2001. 00046.x (Pubitemid 32097021)
151. Mills J., Charest D. L., Lam F., Beyreuther K., Ida N., Pelech S. L., Reiner P. B., Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway. The Journal of Neuroscience 1997 17 24 9415 9422 2-s2.0-0031453010 (Pubitemid 28006386)
152. van Gassen G., de Jonghe C., Nishimura M., Yu G., Kuhn S., St George-Hyslop P., van Broeckhoven C., Evidence that the β -catenin nuclear translocation assay allows for measuring presenilin 1 dysfunction. Molecular Medicine 2000 6 7 570 580 2-s2.0-0034218323
153. Gantier R., Gilbert D., Dumanchin C., Campion D., Davoust D., Toma F., Frébourg T., The pathogenic L392V mutation of presenilin 1 decreases the affinity to glycogen synthase kinase-3 β Neuroscience Letters 2000 283 3 217 220 2-s2.0-0034646792 10.1016/S0304-3940(00)00949-6 (Pubitemid 30168971)
154. Pei J. J., Tanaka T., Tung Y. C., Braak E., Iqbal K., Grundke-Iqbal I., Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. Journal of Neuropathology and Experimental Neurology 1997 56 1 70 78 2-s2.0-0030635495 (Pubitemid 127470328)
155. Wang J. Z., Wu Q., Smith A., Grundke-Iqbal I., Iqbal K., τ is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase. FEBS Letters 1998 436 1 28 34 2-s2.0-0032566623 10.1016/S0014-5793(98) 01090-4 (Pubitemid 28454601)
156. Singh T. J., Haque N., Grundke-Iqbal I., Iqbal K., Rapid Alzheimer-like phosphorylation of tau by the synergistic actions of non-proline-dependent protein kinases and GSK-3. FEBS Letters 1995 358 3 267 272 2-s2.0-0028967378 10.1016/0014-5793(94)01445-7
157. Utton M. A., Vandecandelaere A., Wagner U., Reynolds C. H., Gibb G. M., Miller C. G. J., Bayley P. M., Anderton B. H., Phosphorylation of tau by glycogen synthase kinase 3 β affects the ability of tau to promote microtubule self-assembly. Biochemical Journal 1997 323 part 3 741 747 2-s2.0-0030908590 (Pubitemid 27202345)
158. Baki L., Marambaud P., Efthimiopoulos S., Georgakopoulos A., Wen P., Cui W., Shioi J., Koo E., Ozawa M., Friedrich V. L. Jr., Robakis N. K., Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex. Proceedings of the National Academy of Sciences of the United States of America 2001 98 5 2381 2386 2-s2.0-0035956921 10.1073/pnas.041603398 (Pubitemid 32209491)
159. Anderson A. J., Cummings B. J., Cotman C. W., Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease: association with pathology. Experimental Neurology 1994 125 2 286 295 2-s2.0-0028210761 10.1006/exnr.1994.1031 (Pubitemid 24076106)
160. Layfield R., Fergusson J., Aitken A., Lowe J., Landon M., Mayer R. J., Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins. Neuroscience Letters 1996 209 1 57 60 2-s2.0-0029970593 10.1016/0304-3940(96) 12598-2 (Pubitemid 26150420)
161. Hashiguchi M., Sobue K., Paudel H. K., 14-3-3 ζ is an effector of tau protein phosphorylation. The Journal of Biological Chemistry 2000 275 33 25247 25254 2-s2.0-0034682667 10.1074/jbc.M003738200
162. Marcus D. L., Strafaci J. A., Miller D. C., Masia S., Thomas C. G., Rosman J., Hussain S., Freedman M. L., Quantitative neuronal c-Fos and c-Jun expression in Alzheimer's disease. Neurobiology of Aging 1998 19 5 393 400 2-s2.0-0032409912 10.1016/S0197-4580(98)00077-3 (Pubitemid 29065488)
163. Kihiko M. E., Tucker H. M., Rydel R. E., Estus S., c-Jun contributes to amyloid β -induced neuronal apoptosis but is not necessary for amyloid β -induced c-jun induction. Journal of Neurochemistry 1999 73 6 2609 2612 2-s2.0-0032728505 10.1046/j.1471-4159.1999.0732609.x
164. Shirazi S. K., Wood J. G., The protein tyrosine kinase, fyn, in Alzheimer's disease pathology. NeuroReport 1993 4 4 435 437 2-s2.0-0027447602 (Pubitemid 23116742)
165. Lambert M. P., Barlow A. K., Chromy B. A., Edwards C., Freed R., Liosatos M., Morgan T. E., Rozovsky I., Trommer B., Viola K. L., Wals P., Zhang C., Finch C. E., Krafft G. A., Klein W. L., Diffusible, nonfibrillar ligands derived from A β 1-42 are potent central nervous system neurotoxins. Proceedings of the National Academy of Sciences of the United States of America 1998 95 11 6448 6453 2-s2.0-11544279355
166. Chopp M., The roles of heat shock proteins and immediate early genes in central nervous system normal function and pathology. Current Opinion in Neurology and Neurosurgery 1993 6 1 6 10 2-s2.0-0027397058 (Pubitemid 23056709)
167. McShea A., Zelasko D. A., Gerst J. L., Smith M. A., Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli. Brain Research 1999 815 2 237 242 2-s2.0-0033537306 10.1016/S0006-8993(98)01135-4 (Pubitemid 29225270)